TipRanks
Go Ultimate55% OFF

Mark Stenhouse Insider Profile

4 Followers

Mark Stenhouse, Director at Phathom Pharmaceuticals, holds 54.12K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Prometheus Biosciences (Ticker: RXDX), holds 29.93K shares in Exact Sciences (Ticker: EXAS).

Mark Stenhouse's Trading History

PHAT
Phathom Pharmaceuticals
May 21, 2026DirectorUninformative Buy―$310.66K
RXDX
Prometheus Biosciences
Jun 16, 2023―Uninformative Sell―$0.00
EXAS
Exact Sciences
Apr 06, 2020―Uninformative Buy751.80K$3.14M

You May Also Like

Mark Stenhouse insider profile FAQ

What stocks does Mark Stenhouse hold?
Mark Stenhouse holds: PHAT, EXAS, RXDX stocks.
What is Mark Stenhouse's role in Phathom Pharmaceuticals?
Mark Stenhouse's role in Phathom Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.